Oncology
Consultant Medical Oncologist & Hemato-Oncologist2 Years of Experience in Medical Oncology
HCG Cancer Center, Hubli
Hubli
Dr. R Shrikanth is a Consultant Medical Oncologist and Hemato-Oncologist in Hubli with experience in the treatment of solid tumours and blood cancers.
His major clinical interests include chemotherapy, targeted therapy, immunotherapy, treatment of hematologic malignancies and multidisciplinary cancer care.
Dr. R Shrikanth completed his MBBS followed by MD in General Medicine and DM in Medical Oncology. He received advanced oncology training at Gujarat Cancer & Research Institute, Ahmedabad.
He has experience in the management of solid tumours, leukemia, lymphoma and other hematologic malignancies, as well as selected pediatric cancers.
Dr. R Shrikanth has also worked with an experienced Bone Marrow Transplant team and has participated in autologous and allogeneic stem cell transplant care.
Dr. R Shrikanth currently practises at HCG Cancer Center, Hubli.
Chemotherapy uses anticancer medicines to destroy or control cancer cells and may be used alone or in combination with other treatments.
Targeted therapy uses medicines designed to act on specific molecular features of cancer cells.
Immunotherapy helps the immune system recognise and attack selected cancer cells.
Medical oncology treatment for solid tumours is planned according to cancer type, stage, molecular characteristics and overall patient condition.
Leukemia treatment may include chemotherapy, targeted therapy, immunotherapy and transplant evaluation depending on disease subtype and risk.
Lymphoma treatment is selected according to lymphoma subtype, stage and individual disease characteristics.
Multiple myeloma treatment may involve systemic therapy and stem cell transplant evaluation in selected patients.
Blood cancer care includes evaluation and systemic treatment of leukemia, lymphoma, myeloma and other hematologic malignancies.
Selected pediatric malignancies require age-appropriate systemic cancer treatment and multidisciplinary care.
Autologous stem cell transplantation uses the patient's own collected stem cells following intensive treatment in selected blood cancers.
Allogeneic transplantation uses stem cells from a suitable donor and may be considered for selected hematologic malignancies.
Clinical trials evaluate new treatment strategies and may offer eligible patients access to investigational cancer therapies under strict protocols.
MBBS, MD (General Medicine), DM (Medical Oncology)
Chemotherapy, Targeted Therapy, Immunotherapy, Solid Tumor Treatment, Leukemia Treatment, Lymphoma Treatment, Multiple Myeloma Treatment, Hematologic Malignancy Treatment, Pediatric Cancer Treatment, Autologous Stem Cell Transplant Support, Allogeneic Stem Cell Transplant Support, Clinical Trial-Based Cancer Therapy
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. R Shrikanth
Yes. Dr. R Shrikanth has worked with an experienced BMT team and has been involved in autologous and allogeneic stem cell transplant care.
Yes. Dr. R Shrikanth has experience in treating hematologic malignancies including leukemia, lymphoma and related blood cancers.
Yes. Dr. R Shrikanth has documented expertise in both targeted therapy and immunotherapy.
Yes. Chemotherapy is one of Dr. R Shrikanth's primary documented treatment modalities.
Dr. R Shrikanth has completed MBBS, MD in General Medicine and DM in Medical Oncology.
Contact us for personalized help or to schedule an appointment.